Clara Nervi;Corrado Spadafora;Patriźia Ĺ;avia;Gugliemo Palombini;Elisabetta Mattei;Rodolfo Nello Lorenzini
发明人:
Corrado Spadafora,Patriźia Ĺ,avia,Elisabetta Mattei,Gugliemo Palombini,Rodolfo Nello Lorenzini,Clara Nervi
申请号:
US10500270
公开号:
US10507207B2
申请日:
2002.12.23
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The invention refers to the use of Reverse Transcriptase (RT) inhibitor compounds for the preparation of pharmaceutical compositions to counteract the loss of cellular differentiation in tumour and non tumour pathologies, said compound being able to bind the hydrophobic pocket on the RT subunit p66. Particularly preferred for such uses are the following compounds: nevirapine, efavirenz, delavirdine, corresponding salts and/or pharmaceutically acceptable derivatives thereof.